These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2892259

  • 1. Nizatidine as maintenance therapy of duodenal ulcer disease in remission.
    Cerulli MA, Cloud ML, Offen WW, Chernish SM, Matsumoto C.
    Scand J Gastroenterol Suppl; 1987; 136():79-83. PubMed ID: 2892259
    [Abstract] [Full Text] [Related]

  • 2. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse. Six-month interim results of a European multicentre study.
    Hentschel E, Schütze K, Reichel W, Kerstan E, Kratochvil P, Brandstätter G, Judmaier G, Keohane PP.
    Scand J Gastroenterol Suppl; 1987; 136():84-8. PubMed ID: 2892260
    [Abstract] [Full Text] [Related]

  • 3. Healing and recurrence of active duodenal ulcer with nizatidine.
    Cloud ML, Offen WW, Matsumoto C, Chernish SM.
    Clin Pharmacol Ther; 1989 Sep; 46(3):310-6. PubMed ID: 2570656
    [Abstract] [Full Text] [Related]

  • 4. Treatment of duodenal ulceration in the United States.
    Dyck WP, Cloud ML, Offen WW, Matsumoto C, Chernish SM.
    Scand J Gastroenterol Suppl; 1987 Sep; 136():47-55. PubMed ID: 2892255
    [Abstract] [Full Text] [Related]

  • 5. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
    Cherner JA, Cloud ML, Offen WW, Latz JE.
    Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
    [Abstract] [Full Text] [Related]

  • 6. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
    Simon B, Cremer M, Dammann HG, Hentschel E, Keohane PP, Mulder H, Müller P, Sarles H.
    Scand J Gastroenterol Suppl; 1987 Jul; 136():61-70. PubMed ID: 2892257
    [Abstract] [Full Text] [Related]

  • 7. Nizatidine: a new histamine receptor blocker in the treatment of active duodenal ulcers.
    Levendoglu H, Mehta B, Wait C, Reddy G, Hatcher C.
    Am J Gastroenterol; 1986 Dec; 81(12):1167-70. PubMed ID: 2878607
    [Abstract] [Full Text] [Related]

  • 8. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study.
    Texter EC, Navab F, Mantell G, Berman R.
    Am J Med; 1986 Oct 24; 81(4B):25-32. PubMed ID: 2877571
    [Abstract] [Full Text] [Related]

  • 9. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ, Hazenberg HJ, Quik RF, Hazenberg BP, de Zwart PA.
    Neth J Med; 1990 Aug 24; 37(1-2):58-62. PubMed ID: 1977089
    [Abstract] [Full Text] [Related]

  • 10. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
    Bovero E, Poletti M, Boero A, Mura BC, Camarri E, Corradini P, Corsini G, Federici G, Curzio M, Gianquinto G.
    Hepatogastroenterology; 1987 Dec 24; 34(6):269-71. PubMed ID: 2892768
    [Abstract] [Full Text] [Related]

  • 11. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
    Arnold R, Beckenbach P, Bock H, Bormann R, Daake H, Dammann HG, Du Bosque G, Fürer M, Geiter B, Hebbeln H.
    Fortschr Med; 1989 Jul 20; 107(21):467-70. PubMed ID: 2570012
    [Abstract] [Full Text] [Related]

  • 12. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M, Holdcroft C.
    Nurse Pract; 1989 Feb 20; 14(2):41-2. PubMed ID: 2564655
    [Abstract] [Full Text] [Related]

  • 13. Nizatidine and ranitidine in the short-term treatment of duodenal ulcer: a cooperative double-blind study of once-daily bedtime administration.
    Pace F, Colombo E, Ferrara A, Prada A, Rocca F, Bianchi Porro G.
    Am J Gastroenterol; 1988 Jun 20; 83(6):643-5. PubMed ID: 2897784
    [Abstract] [Full Text] [Related]

  • 14. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E.
    Z Gastroenterol; 1985 Dec 20; 23(12):665-9. PubMed ID: 2868581
    [Abstract] [Full Text] [Related]

  • 15. Safety of nizatidine in clinical trials conducted in the USA and Europe.
    Cloud ML.
    Scand J Gastroenterol Suppl; 1987 Dec 20; 136():29-36. PubMed ID: 2892253
    [Abstract] [Full Text] [Related]

  • 16. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Price AH, Brogden RN.
    Drugs; 1988 Nov 20; 36(5):521-39. PubMed ID: 2905640
    [Abstract] [Full Text] [Related]

  • 17. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
    Naccaratto R, Cremer M, Dammann HG, Keohane PP, Mulder H, Sarles H, Simon B.
    Scand J Gastroenterol Suppl; 1987 Nov 20; 136():71-8. PubMed ID: 2892258
    [Abstract] [Full Text] [Related]

  • 18. Influence of cigarette smoking on recurrence of duodenal ulcer.
    Sumii K, Kimura M, Morikawa A, Haruma K, Yoshihara M, Teshima H, Kajiyama G.
    Jpn J Med; 1989 Nov 20; 28(4):492-5. PubMed ID: 2572714
    [Abstract] [Full Text] [Related]

  • 19. [Nizatidine].
    Romero M, Franzosi MG.
    Medicina (Firenze); 1989 Nov 20; 9(1):93-6. PubMed ID: 2567957
    [Abstract] [Full Text] [Related]

  • 20. Nizatidine (AXID).
    Med Lett Drugs Ther; 1988 Aug 12; 30(772):77-8. PubMed ID: 2899835
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.